From: Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma
Factor | Entire cohort | Esophagus | GE junction | Stomach |
---|---|---|---|---|
(n = 174) n (%) | (n = 60) n (%) | (n = 45) n (%) | (n = 69) n (%) | |
Age (years) | ||||
Mean Median (Range) | 70.2 70.0 (42.6-94.4) | 67.9 66.0 (48.2-88.5) | 69.9 68.7 (48.7-88.6) | 72.4 73.9 (42.6-94.4) |
Sex | ||||
Women Men | 40 (23.0) 134 (77.0) | 6 (10.0) 54 (90.0) | 12 (26.7) 33 (73.3) | 22 (31.9) 47 (68.1) |
T stage | ||||
T1 T2 T3 T4 Unknown | 19 (10.9) 32 (18.4) 93 (53.4) 27 (15.5) 3 (1.7) | 9 (15.0) 10 (16.7) 34 (56.7) 6 (10.0) 1 (1.7) | 3 (6.7) 4 (8.9) 33 (73.3) 4 (8.9) 1 (2.2) | 7 (10.1) 18 (26.1) 26 (37.7) 17 (24.6) 1 (1.4) |
N stage | ||||
N0 N1 N2 N3 | 59 (33.9) 30 (17.2) 41 (23.6) 44 (25.3) | 15 (25.0) 11 (18.3) 15 (25.0) 19 (31.7) | 12 (26.7) 7 (15.6) 14 (31.1) 12 (26.7) | 32 (46.4) 12 (17.4) 12 (17.4) 13 (18.8) |
Number of examined nodes | ||||
Mean Median Range Unknown | 30.3 29.0 1–112 14 | 36.6 33.5 10–72 2 | 29.7 28.0 8–48 1 | 24.3 22.0 1–112 11 |
M stage | ||||
M0 M1 | 152 (87.4) 22 (12.6) | 52 (86.7) 8 (13.3) | 40 (88.9) 5 (11.1) | 60 (87.0) 9 (13.0) |
R classification | ||||
R0 R1 R2 | 121 (69.5) 43 (24.7) 10 (5.7) | 38 (63.3) 21 (35.0) 1 (1.7) | 30 (66.7) 13 (28.9) 2 (4.4) | 53 (76.8) 9 (13.0) 7 (10.1) |
Differentiation grade | ||||
High Intermediate Low | 8 (4.6) 53 (30.5) 113 (64.9) | 4 (6.7) 26 (43.3) 30 (50.0) | 1 (2.2) 13 (28.9) 31 (68.9) | 3 (4.3) 14 (20.3) 52 (75.4) |
Lauren classification | ||||
Intestinal Mixed Diffuse | 120 (69.0) 9 (5.2) 45 (25.9) | 54 (90.0) 4 (6.7) 2 (3.3) | 31 (68.9) 3 (6.7) 11 (24.4) | 35 (50.7) 2 (2.9) 32 (46.4) |
Intestinal metaplasia background | ||||
No Yes | 101 (58.0) 73 (42.0) | 37 (61.7) 23 (38.3) | 34 (75.6) 11 (24.4) | 30 (43.5) 39 (56.5) |
Adjuvant therapy | ||||
No Chemoradiotherapy Chemotherapy Radiotherapy | 161 (92.5) 11 (6.3) 1 (0.6) 1 (0.6) | 55 (91.7) 3 (5.0) 1 (1.7) 1 (1.7) | 42 (93.3) 3 (6.7) | 64 (92.8) 5 (7.2) |
Follow-up (years) | ||||
Mean Median Range | 3.25 2.28 0.01-8.95 | 3.36 2.47 0.26-8.95 | 3.06 2.17 0.01-8.89 | 3.28 2.09 0.01-8.85 |
Recurrence | ||||
No Yes Unknown/Not applicable | 62 (35.6) 78 (44.8) 34 (19.5) | 20 (33.3) 29 (48.3) 11 (18.3) | 15 (33.3) 22 (48.9) 8 (17.8) | 27 (39.1) 27 (39.1) 15 (21.7) |
Vital status | ||||
Alive Dead | 48 (27.6) 126 (72.4) | 21 (35.0) 39 (65.0) | 8 (17.8) 37 (82.2) | 19 (27.5) 50 (72.5) |